» Authors » Jonathon Hinton

Jonathon Hinton

Explore the profile of Jonathon Hinton including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 1257
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tarpey P, Behjati S, Cooke S, Van Loo P, Wedge D, Pillay N, et al.
Nat Genet . 2013 Jun; 45(8):923-6. PMID: 23770606
Chondrosarcoma is a heterogeneous collection of malignant bone tumors and is the second most common primary malignancy of bone after osteosarcoma. Recent work has identified frequent, recurrent mutations in IDH1...
2.
Bignell G, Greenman C, Davies H, Butler A, Edkins S, Andrews J, et al.
Nature . 2010 Feb; 463(7283):893-8. PMID: 20164919
The cancer genome is moulded by the dual processes of somatic mutation and selection. Homozygous deletions in cancer genomes occur over recessive cancer genes, where they can confer selective growth...
3.
Raymond F, Tarpey P, Edkins S, Tofts C, OMeara S, Teague J, et al.
Am J Hum Genet . 2007 Apr; 80(5):982-7. PMID: 17436253
We have identified one frameshift mutation, one splice-site mutation, and two missense mutations in highly conserved residues in ZDHHC9 at Xq26.1 in 4 of 250 families with X-linked mental retardation...
4.
Tarpey P, Stevens C, Teague J, Edkins S, OMeara S, Avis T, et al.
Am J Hum Genet . 2006 Dec; 79(6):1119-24. PMID: 17186471
In a systematic sequencing screen of the coding exons of the X chromosome in 250 families with X-linked mental retardation (XLMR), we identified two nonsense mutations and one consensus splice-site...
5.
Hunter C, Smith R, Cahill D, Stephens P, Stevens C, Teague J, et al.
Cancer Res . 2006 Apr; 66(8):3987-91. PMID: 16618716
Malignant gliomas have a very poor prognosis. The current standard of care for these cancers consists of extended adjuvant treatment with the alkylating agent temozolomide after surgical resection and radiotherapy....
6.
Bignell G, Smith R, Hunter C, Stephens P, Davies H, Greenman C, et al.
Genes Chromosomes Cancer . 2005 Sep; 45(1):42-6. PMID: 16175573
The protein kinase gene family is the most frequently mutated in human cancer. Previous work has documented activating mutations in the KIT receptor tyrosine kinase in testicular germ-cell tumors (TGCT)....
7.
Davies H, Hunter C, Smith R, Stephens P, Greenman C, Bignell G, et al.
Cancer Res . 2005 Sep; 65(17):7591-5. PMID: 16140923
Protein kinases are frequently mutated in human cancer and inhibitors of mutant protein kinases have proven to be effective anticancer drugs. We screened the coding sequences of 518 protein kinases...
8.
Stephens P, Edkins S, Davies H, Greenman C, Cox C, Hunter C, et al.
Nat Genet . 2005 May; 37(6):590-2. PMID: 15908952
We examined the coding sequence of 518 protein kinases, approximately 1.3 Mb of DNA per sample, in 25 breast cancers. In many tumors, we detected no somatic mutations. But a...